# ziprasidone mesylate

NDC: 68083-340
Generic name: ziprasidone mesylate
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20191226

FDA application: ANDA211908

## Active ingredients

- ZIPRASIDONE MESYLATE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-340"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-340
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=77a10f48-e300-465f-81b5-54be38daa4b3